Published in Biotech Business Week, March 16th, 2009
"NHERF2 enhances Kv1.5 activity and cell surface expression as determined by electrophysiology and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.